Journal
CIRCULATION
Volume 119, Issue 16, Pages 2250-2294Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.109.192230
Keywords
AHA Scientific Statements; pulmonary hypertension; pulmonary arterial hypertension; hemodynamics; prostacyclin; endothelin receptor antagonists; phosphodiesterase inhibitors